comparemela.com

Latest Breaking News On - தடுப்பூசி நோய் எதிர்ப்பு சக்தி - Page 3 : comparemela.com

FDA: Only small percentage of vaccinees reported side effects

endIndex: Metro Manila (CNN Philippines, April 23) – Only 2.45% of over one million individuals who received COVID-19 vaccines in the country have experienced side effects, Food and Drug Administration Director General Eric Domingo reported on Friday. He said 497,837 have received their first dose of the CoronaVac vaccine made by Chinese drugmaker Sinovac, while 508,674 got their first shot of the vaccine developed by British-Swedish firm AstraZeneca. Ninety-five percent or 24,330 showed minor and non-serious side effects, such as temporary high blood pressure, headaches, pain in the injection side, dizziness, rashes, or fever. The FDA also reported 344 serious adverse events. There were also 24 deaths recorded after immunization, but Domingo said 19 were found to be coincidental or not related to the vaccine. Of the 24 fatalities, 11 contracted severe COVID-19 before the full effect of the vaccine set in, eight died of heart attack or stroke, three succumbed to other infectio

Lawmaker hits lack of indemnification guidelines since start of COVID-19 vaccination program

endIndex: Metro Manila (CNN Philippines, April 21)  Gabriela Party Rep. Arlene Brosas on Wednesday lamented the lack of implementation guidelines on indemnifying vaccine recipients who may experience serious side effects after receiving a coronavirus shot more than a month since the local inoculation drive started. PhilHealth is currently finalizing the specific guidelines for approval of the board and then eventually the management, Dr. Mary Antonette Remonte of the Philippine Health Insurance Corporation told a House hearing when Brosas asked for a copy of the indemnification guidelines. We have to study carefully the law as well as we have to consider the available resources as provided by law, Remonte added, noting that the indemnification fund is new and that PhilHealth does not have much experience in managing this.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.